Prescription medication · Alpha-2 Agonist (Ophthalmic)
brimonidine ophthalmic
Also sold as Alphagan P. Alphagan P eye drops are used to lower high pressure inside your eye.
Data updated 2026-05-15
- 1
- InteractionFew interactions
- 99% less
- Generic vs brandHuge savings
- $37.34
- Brand price (NADAC)
What the data shows
brimonidine ophthalmic (Alphagan P) is a prescription Alpha-2 Agonist (Ophthalmic), whose generic costs a fraction of the brand (about 99% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
brimonidine ophthalmic (Alphagan P) is a prescription Alpha-2 Agonist (Ophthalmic). Alphagan P eye drops are used to lower high pressure inside your eye.
Alphagan P eye drops help lower pressure in the eye. It is used for people with open-angle glaucoma or ocular hypertension.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$37.34/unit
Generic Price
$0.46/unit
Generic Savings
99%
Generic Available
Yes (20 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Alphagan P eye drops are used to lower high pressure inside your eye.
Common side effects
Allergic conjunctivitis (eye allergy), Eye redness, Eye itching
Key warnings
Alphagan P may worsen problems caused by poor blood flow.
The sections below are summarized in plain English from brimonidine ophthalmic's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Alphagan P is an alpha-2 adrenergic agonist. It works by decreasing the amount of fluid your eye makes. It also helps increase the amount of fluid that drains from your eye, which lowers eye pressure.
Serious Warnings
Alphagan P may worsen problems caused by poor blood flow. Use caution if you have depression, problems with blood flow to your brain or heart, Raynaud’s phenomenon, low blood pressure when standing up, or thromboangiitis obliterans. Do not touch the tip of the container to your eye or any other surface. This can cause the solution to become contaminated and lead to serious eye damage and vision loss.
Known Drug Interactions
( 7.2 ) Tricyclic antidepressants may potentially blunt the hypotensive effect of systemic clonidine. 7.3 Tricyclic Antidepressants Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.
Mechanism: Both medications work in a similar way to lower blood pressure, which may cause an additive effect when used together.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I use Alphagan P if I am under 2 years old?
What should I do if my eyes get irritated after using Alphagan P?
Can Alphagan P affect my blood pressure?
Can I use Alphagan P with other eye drops?
What if the Alphagan P solution changes color?
Can I drive after using Alphagan P?
What should I do if I accidentally swallow Alphagan P?
Can I wear contact lenses while using Alphagan P?
Is it okay to share my Alphagan P eye drops with someone else?
What should I do if I experience an allergic reaction to Alphagan P?
What are the common side effects of brimonidine ophthalmic?
Does brimonidine ophthalmic interact with other medications?
What drug class is brimonidine ophthalmic?
Is there a generic version of brimonidine ophthalmic?
What pregnancy or breastfeeding source fields are listed for brimonidine ophthalmic?
Related Medications in Alpha-2 Agonist (Ophthalmic)
Other drugs grouped near brimonidine ophthalmic - same-class peers and common alternatives.
aflibercept
Eylea
AHZANTIVE is a medicine used to treat certain eye problems.
Compare with brimonidine ophthalmic →
artificial tears
Refresh, Systane
Artificial tears are eye drops that lubricate your eyes.
Compare with brimonidine ophthalmic →
bevacizumab (ophthalmic)
Avastin
Avastin is a medicine that blocks a protein called vascular endothelial growth factor (VEGF).
Compare with brimonidine ophthalmic →
bimatoprost
Lumigan
Bimatoprost eye drops help lower pressure in the eye.
Compare with brimonidine ophthalmic →
brimonidine/timolol
Combigan
Combigan eye drops contain two medicines that lower pressure in the eye.
Compare with brimonidine ophthalmic →
Compare brimonidine ophthalmic vs aflibercept side-by-side →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on brimonidine ophthalmic
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for brimonidine ophthalmic
The FDA label for brimonidine ophthalmic (sold under brand names such as Alphagan P) classifies it as a prescription-only medication in the Alpha-2 Agonist (Ophthalmic) class. Alphagan P eye drops are used to lower high pressure inside your eye. Official labeling lists 8 commonly reported side effects, including Allergic conjunctivitis (eye allergy), Eye redness, Eye itching.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.46 versus $37.34 for the brand - a 99% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: September 18, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages